doi: 10.3389/fnut.2025.1534000 Received 25 November 2024 Accepted 11 March 2025 Published 09 April 2025 Volume 12 - 2025 Edited by Luciana Mosca, Sapienza University of Rome, Italy Reviewed by Runnan Grace Li, University of Kentucky, United States Flores Naselli, University of Palermo, Italy Di Zhu, Chi Forest (Beijing) Food Technology Group Co., Ltd., China Updates Copyright 2025 Rana, Katiyar, Arun, Berrios and Kumar
[10] All mutations that cause G6PD deficiency are found on the long arm of the X chromosome, on band Xq28
Scenario 2: Inadvertent Exposure 32-year-old woman with T2DM on semaglutide, presents at 8 weeks gestation G2P0L0A1.First trimester pregnancy loss due to high blood glucose levels Management- Stop Sema Reassurance based on current evidence Detailed risk counseling using available data HbA1C specially Enhanced monitoring with detailed ultrasound Multidisciplinary approach Documentation and registry participation if available What Guidelines Say
Similar to cagrilintide, pramlintide is primarily eliminated via the kidneys and, in a pharmacokinetic study in participants with type 1 diabetes, no statistically significant differences were noted in total (AUC 0- ) and peak ( C max ) exposure after administration of a single pramlintide 60 g dose in participants with mild, moderate or severe renal impairment compared with those with normal renal function, although inter-patient variability was high [20]